153 related articles for article (PubMed ID: 11083853)
1. Disease outcome subsequent to primary and secondary urogenital infection with murine or human biovars of Chlamydia trachomatis.
Ramsey KH; DeWolfe JL; Salyer RD
Infect Immun; 2000 Dec; 68(12):7186-9. PubMed ID: 11083853
[TBL] [Abstract][Full Text] [Related]
2. Prior genital tract infection with a murine or human biovar of Chlamydia trachomatis protects mice against heterotypic challenge infection.
Ramsey KH; Cotter TW; Salyer RD; Miranpuri GS; Yanez MA; Poulsen CE; DeWolfe JL; Byrne GI
Infect Immun; 1999 Jun; 67(6):3019-25. PubMed ID: 10338514
[TBL] [Abstract][Full Text] [Related]
3. Factors influencing the induction of infertility in a mouse model of Chlamydia trachomatis ascending genital tract infection.
Pal S; Hui W; Peterson EM; de la Maza LM
J Med Microbiol; 1998 Jul; 47(7):599-605. PubMed ID: 9839564
[TBL] [Abstract][Full Text] [Related]
4. Intravaginal inoculation of mice with the Chlamydia trachomatis mouse pneumonitis biovar results in infertility.
de la Maza LM; Pal S; Khamesipour A; Peterson EM
Infect Immun; 1994 May; 62(5):2094-7. PubMed ID: 8168974
[TBL] [Abstract][Full Text] [Related]
5. Protection against infertility in a BALB/c mouse salpingitis model by intranasal immunization with the mouse pneumonitis biovar of Chlamydia trachomatis.
Pal S; Fielder TJ; Peterson EM; de la Maza LM
Infect Immun; 1994 Aug; 62(8):3354-62. PubMed ID: 8039906
[TBL] [Abstract][Full Text] [Related]
6. An experimental model for salpingitis due to Chlamydia trachomatis and residual tubal infertility in the mouse.
Zana J; Thomas D; Muffat-Joly M; de Brux J; Pocidalo JJ; Orfila J; Carbon C; Salat-Baroux J
Hum Reprod; 1990 Apr; 5(3):274-8. PubMed ID: 2351710
[TBL] [Abstract][Full Text] [Related]
7. Mouse strain-dependent variation in the course and outcome of chlamydial genital tract infection is associated with differences in host response.
Darville T; Andrews CW; Laffoon KK; Shymasani W; Kishen LR; Rank RG
Infect Immun; 1997 Aug; 65(8):3065-73. PubMed ID: 9234755
[TBL] [Abstract][Full Text] [Related]
8. Chlamydia trachomatis serovar E isolates from patients with different clinical manifestations have similar courses of infection in a murine model: host factors as major determinants of C trachomatis mediated pathogenesis.
Lyons JM; Ito JI; Morré SA
J Clin Pathol; 2004 Jun; 57(6):657-9. PubMed ID: 15166277
[TBL] [Abstract][Full Text] [Related]
9. Infertility as a consequence of chlamydial infection of the upper genital tract in female mice.
Swenson CE; Schachter J
Sex Transm Dis; 1984; 11(2):64-7. PubMed ID: 6463810
[TBL] [Abstract][Full Text] [Related]
10. Acquired homotypic and heterotypic immunity against oculogenital Chlamydia trachomatis serovars following female genital tract infection in mice.
Lyons JM; Morré SA; Airo-Brown LP; Peña AS; Ito JI
BMC Infect Dis; 2005 Nov; 5():105. PubMed ID: 16293190
[TBL] [Abstract][Full Text] [Related]
11. Murine model of ocular infection by a human biovar of Chlamydia trachomatis.
Whittum-Hudson JA; O'Brien TP; Prendergast RA
Invest Ophthalmol Vis Sci; 1995 Sep; 36(10):1976-87. PubMed ID: 7657540
[TBL] [Abstract][Full Text] [Related]
12. Frameshift mutations in a single novel virulence factor alter the in vivo pathogenicity of Chlamydia trachomatis for the female murine genital tract.
Sturdevant GL; Kari L; Gardner DJ; Olivares-Zavaleta N; Randall LB; Whitmire WM; Carlson JH; Goheen MM; Selleck EM; Martens C; Caldwell HD
Infect Immun; 2010 Sep; 78(9):3660-8. PubMed ID: 20547745
[TBL] [Abstract][Full Text] [Related]
13. Infertility in mice infected genitally with a human strain of Chlamydia trachomatis.
Tuffrey M; Falder P; Gale J; Quinn R; Taylor-Robinson D
J Reprod Fertil; 1986 Sep; 78(1):251-60. PubMed ID: 3761270
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of genital Chlamydia trachomatis in Iran: a systematic review and meta-analysis.
Ahmadi MH; Mirsalehian A; Bahador A
Pathog Glob Health; 2015 Sep; 109(6):290-9. PubMed ID: 26343285
[TBL] [Abstract][Full Text] [Related]
15. A murine model for the study of Chlamydia trachomatis genital infections during pregnancy.
Pal S; Peterson EM; De La Maza LM
Infect Immun; 1999 May; 67(5):2607-10. PubMed ID: 10225927
[TBL] [Abstract][Full Text] [Related]
16. Variation in virulence among oculogenital serovars of Chlamydia trachomatis in experimental genital tract infection.
Ito JI; Lyons JM; Airo-Brown LP
Infect Immun; 1990 Jun; 58(6):2021-3. PubMed ID: 2341189
[TBL] [Abstract][Full Text] [Related]
17. Differences in innate immune responses (in vitro) to HeLa cells infected with nondisseminating serovar E and disseminating serovar L2 of Chlamydia trachomatis.
Dessus-Babus S; Darville TL; Cuozzo FP; Ferguson K; Wyrick PB
Infect Immun; 2002 Jun; 70(6):3234-48. PubMed ID: 12011019
[TBL] [Abstract][Full Text] [Related]
18. The prevalence, risks, and management of Chlamydia trachomatis infections in fertile and infertile patients from the high socioeconomic bracket of the South African population.
Wessels PH; Viljoen GJ; Marais NF; de Beer JA; Smith M; Gericke A
Fertil Steril; 1991 Sep; 56(3):485-8. PubMed ID: 1894026
[TBL] [Abstract][Full Text] [Related]
19. The anti-idiotypic antibody to chlamydial glycolipid exoantigen (GLXA) protects mice against genital infection with a human biovar of Chlamydia trachomatis.
Whittum-Hudson JA; Rudy D; Gèrard H; Vora G; Davis E; Haller PK; Prattis SM; Hudson AP; Saltzman WM; Stuart ES
Vaccine; 2001 Jul; 19(28-29):4061-71. PubMed ID: 11427283
[TBL] [Abstract][Full Text] [Related]
20. Induction of protective immunity against a Chlamydia trachomatis genital infection in three genetically distinct strains of mice.
Pal S; Peterson EM; de la Maza LM
Immunology; 2003 Nov; 110(3):368-75. PubMed ID: 14632665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
